Totals
- Total revenue
- $3,102,549
- Total expenses
- $2,741,752
- Contributions and grants received
- $2,021,099
- Grants paid
- $137,047
- Program service revenue
- $423,855
- Investment income
- $115,754
- Other revenue
- $541,841
- Total assets, end of year
- $6,096,770
- Total liabilities, end of year
- $549,485
- Net assets or fund balances, end of year
- $5,547,285
- Program services expenses (Part IX)
- $1,591,169
- Management and general expenses
- $605,174
- Fundraising expenses
- $545,409
- Program service expenses (Part III)
- $1,591,169
Program services were 58.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f , All other contributions, gifts and grants
$2,021,099
-
2a , Program service revenue: CORPORATE SUPPORT
total $200,292 · related or exempt $200,292
-
2b , Program service revenue: OTHER PROGRAM REVENUE
total $133,713 · related or exempt $133,713
-
2c , Program service revenue: CLINICAL TRIALS FEES
total $89,500 · related or exempt $89,500
-
2d , Program service revenue: GREAT PROGRAM
total $350 · related or exempt $350
-
3 , Investment income
total $115,754 · excluded $115,754
-
8a , Fundraising events: gross income
$607,023
-
8b , Fundraising events: direct expenses
$65,182
-
8c , Net income from fundraising events
total $541,841 · excluded $541,841
Functional expenses
Part IX, the statement of functional expenses.
-
1 , Grants to domestic organizations and governments
total $70,000 · program services $70,000
-
3 , Grants to foreign organizations and individuals
total $67,047 · program services $67,047
-
5 , Compensation of officers, directors and key employees
total $575,334 · program services $414,658 · management and general $35,181 · fundraising $125,495
-
7 , Other salaries and wages
total $1,300,761 · program services $664,975 · management and general $403,113 · fundraising $232,673
-
9 , Other employee benefits
total $74,784 · program services $51,863 · management and general $9,405 · fundraising $13,516
-
10 , Payroll taxes
total $131,626 · program services $90,980 · management and general $15,865 · fundraising $24,781
-
11c , Fees: accounting
total $17,999 · program services $8,330 · management and general $8,047 · fundraising $1,622
-
11f , Fees: investment management
total $23,929 · management and general $23,929
-
11g , Fees: other
total $145,621 · program services $67,390 · management and general $65,104 · fundraising $13,127
-
12 , Advertising and promotion
total $1,322 · fundraising $1,322
-
13 , Office expenses
total $53,918 · program services $34,864 · management and general $1,743 · fundraising $17,311
-
14 , Information technology
total $61,008 · program services $60,164 · management and general $800 · fundraising $44
-
16 , Occupancy
total $1,400 · program services $605 · management and general $795
-
17 , Travel
total $55,675 · program services $17,909 · management and general $18,129 · fundraising $19,637
-
19 , Conferences, conventions and meetings
total $20,820 · program services $14,637 · management and general $4,888 · fundraising $1,295
-
22 , Depreciation, depletion and amortization
total $1,405 · fundraising $1,405
-
23 , Insurance
total $7,691 · program services $2,841 · management and general $4,060 · fundraising $790
-
24a , Other expenses: PROGRAMS AND PRODUCTION
total $42,671 · program services $222 · fundraising $42,449
-
24b , Other expenses: DUES AND SUBSCRIPTIONS
total $30,442 · program services $9,841 · management and general $2,175 · fundraising $18,426
-
24c , Other expenses: BANK CHARGES AND OTHER
total $13,880 · program services $296 · management and general $1,125 · fundraising $12,459
-
24d , Other expenses: MISCELLANEOUS
total $13,056 · program services $2,000 · fundraising $11,056
-
24e , All other expenses
total $31,363 · program services $12,547 · management and general $10,815 · fundraising $8,001
Balance sheet
Part X, book values.
-
1 , Cash, non-interest-bearing
beginning of year $306,900 · end of year $144,131
-
2 , Savings and temporary cash investments
beginning of year $1,329,112 · end of year $1,376,612
-
3 , Pledges and grants receivable
beginning of year $743,491 · end of year $1,255,441
-
4 , Accounts receivable
beginning of year $321,354 · end of year $98,459
-
9 , Prepaid expenses and deferred charges
beginning of year $20,676 · end of year $123,323
-
10a , Land, buildings and equipment: cost or other basis
$23,141
-
10b , Land, buildings and equipment: accumulated depreciation
$18,866
-
10c , Land, buildings and equipment, net
beginning of year $3,253 · end of year $4,275
-
11 , Investments: publicly traded securities
beginning of year $2,674,392 · end of year $3,094,529
-
17 , Accounts payable and accrued expenses
beginning of year $200,093 · end of year $189,323
-
18 , Grants payable
beginning of year $141,218 · end of year $41,546
-
19 , Deferred revenue
beginning of year $248,241 · end of year $318,616
-
27 , Net assets without donor restrictions
beginning of year $1,961,656 · end of year $2,043,179
-
28 , Net assets with donor restrictions
beginning of year $2,847,970 · end of year $3,504,106
Mission and programs · 2024
Mission
BEYOND CELIAC UNITES WITH PATIENTS AND PARTNERS TO DRIVE DIAGNOSIS, ADVANCE RESEARCH, AND ACCELERATE THE DISCOVERY OF NEW TREATMENTS AND A CURE.
Activities or mission (Part I)
BEYOND CELIAC UNITES WITH PATIENTS AND PARTNERS TO DRIVE DIAGNOSIS, ADVANCE RESEARCH, AND ACCELERATE THE DISCOVERY OF NEW TREATMENTS AND A CURE FOR CELIAC DISEASE.
-
WE SUPPORT STUDIES, BASED ON OUR COMMUNITY'S NEEDS, THAT QUICKLY TRANSLATE FROM SCIENTIFIC DISCOVERY INTO CLINICAL USE, WITH THE GOAL OF ADVANCING EFFECTIVE TREATMENTS. AS OF FY25, BEYOND CELIAC HAS AWARDED MORE THAN $3.2 MILLION IN GRANTS, SUPPORTING BOTH EARLY-CAREER AND ESTABLISHED INVESTIGATORS. THE LATEST GRANTS FOCUS ON NON-INVASIVE BIOMARKERS, MICROBIOME RESEARCH, IMMUNE TOLERANCE RESTORATION, AND NEUROCOGNITIVE IMPACTS.SELECT AWARDS INCLUDE:1. NIGEL HOGGARD, MD, AND IAIN CROALL, PHD (UNIVERSITY OF SHEFFIELD, UK): ASSESSING TG6 ANTIBODIES FOR CLINICAL PRACTICE.2. MANDEEP SINGH, PHD (UNIVERSITY OF SYDNEY, AUS) TARGETING MUTANT T-CELLS IN NON-RESPONSIVE CELIAC DISEASE.3. MICHAEL FITZPATRICK, DPHIL (UNIVERSITY OF OXFORD, UK): NOVEL BIOMARKERS OF MUCOSAL DAMAGE FOR DIAGNOSIS AND MONITORING.4. ROK SEON CHOUNG, MD, PHD (MAYO CLINIC): PREDICTORS OF PROGRESSIVE CELIAC DISEASE PHENOTYPES.5. SONIA GONCALVES PEREIRA, PHD (INSTITUTO POLITECNICO DE LEIRIA, PORTUGAL): EXPLORING GLUTEN-MICROBIOTA INTERACTIONS IN DISEASE PROGRESS.6. KATI JUUTI-UUSITALO, PHD (TAMPERE UNIVERSITY, FINLAND): DEVELOPMENT OF A PATIENT-DERIVED 2D INTESTINAL MODEL.THESE GRANTS ADDRESS CRITICAL BARRIERS IN THE FIELD, INCLUDING A LACK OF FUNDING, UNDERDIAGNOSIS, AND LIMITED PUBLIC AND CLINICAL AWARENESS. THEY ALIGN WITH OUR FOUR STRATEGIC PRIORITIES: TRANSLATIONAL RESEARCH, EVIDENCE GENERATION, CLINICAL TRIAL ACCELERATION, AND OUR VENTURE PHILANTHROPY PROGRAM THROUGH BEYOND CELIAC INVESTMENTS (BCI).
Expenses $137,087 · Grants $137,047 · Revenue $423,858
-
THIS EVIDENCE INFORMS RESEARCH PRIORITIES, SUPPORTS FUNDING APPLICATIONS, AND ENSURES PATIENT EXPERIENCES SHAPE THE PATH TOWARD NEW TREATMENTS. WITH UP TO 80% OF CELIAC DISEASE CASES STILL UNDIAGNOSED OR MISDIAGNOSED, GO BEYOND CELIAC INSIGHTS PLAYS A VITAL ROLE IN BRIDGING THE GAP BETWEEN LIVED EXPERIENCE AND SCIENTIFIC ADVANCEMENT. THE SURVEY PLATFORM HAS ENHANCED OUTREACH AND INCREASED COMMUNITY PARTICIPATION IN RESEARCH. BEYOND CELIAC ALSO CONNECTS PATIENTS TO CLINICAL TRIALS, ACCELERATING ENROLLMENT AND FACILITATING DRUG DEVELOPMENT. THESE EFFORTS ARE INSTRUMENTAL TO DE-RISKING THE THERAPEUTIC PIPELINE AND DRAWING INCREASED INTEREST FROM INVESTORS, PHARMACEUTICAL COMPANIES, AND BIOTECH. BEYOND CELIAC LEADS A PRECOMPETITIVE COALITION OF MULTIDISCIPLINARY STAKEHOLDERS INVOLVED IN THE DEVELOPMENT OF POTENTIAL THERAPIES FOR CELIAC DISEASE.
Expenses $1,454,082
-
BEYOND CELIAC INVESTMENTS (BCI) VENTURE PHILANTHROPY PROGRAM LAUNCHED A CATALYST PROGRAM TO SCREEN FOR EARLY-STAGE CANDIDATES WITH THE POTENTIAL FOR TRANSFORMATIONAL EFFICACY IN CELIAC DISEASE. THE INAUGURAL PROPOSAL PROCESS IDENTIFIED THE FIRST INVESTMENTS NOW PENDING THROUGH BCI.
-
BEYOND CELIAC SCIENCE TEAM MEMBERS PRESENTED AT MAJOR MEETINGS, INCLUDING THE AMERICAN ACADEMY OF NEUROLOGY CONFERENCE AND DIGESTIVE DISEASE WEEK. ORIGINAL RESEARCH WAS PUBLISHED IN THE JOURNAL OF CLINICAL MEDICINE AND DIGESTIVE DISEASES AND SCIENCES.ADDITIONAL PROGRAM ACTIVITIES INCLUDING PATIENT, AMBASSADOR, AND OTHER PROGRAMS. REACH BEYOND CELIAC PROGRAMS THROUGH OUR REACH BEYOND CELIAC INITIATIVE, WE EMPOWER COMMUNITY LEADERS THROUGH THE AMBASSADOR PROGRAM, INTERN PROGRAM, AND OTHER VOLUNTEER-DRIVEN ENGAGEMENT. AMBASSADORS TAILOR THEIR EFFORTS TO THEIR COMMUNITIES' HOSTING EVENTS, FOSTERING PEER-TO-PEER SUPPORT, AND RAISING AWARENESS NATIONWIDE. OUR INTERNS AND AMBASSADORS COLLABORATE WITH STAFF ON LOCAL OUTREACH, CONTENT DEVELOPMENT, SURVEY CREATION, WEB DEVELOPMENT, AND ADVOCACY INITIATIVES, STRENGTHENING OUR NATIONAL PRESENCE AND EXPANDING THE ORGANIZATION'S REACH AND IMPACT. PATIENT EDUCATION AND SUPPORT PROGRAMS BEYOND CELIAC PROVIDES ESSENTIAL EDUCATIONAL RESOURCES TO PATIENTS AT ALL STAGES OF THEIR CELIAC JOURNEY. OUR "NEWLY DIAGNOSED GUIDE" OFFERS COMPREHENSIVE TOOLS FOR UNDERSTANDING CELIAC DISEASE AND INITIATING A GLUTEN-FREE DIET. WE ALSO PUBLISH DOWNLOADABLE TOOLKITS AND HOST WEBINARS FOR SPECIFIC POPULATIONS, STUDENTS, PARENTS, AND ADULTS COVERING TOPICS LIKE READING FOOD LABELS, MANAGING CROSS-CONTAMINATION, AND NAVIGATING SOCIAL SETTINGS. THROUGH TOWN HALLS, VIRTUAL Q&A SESSIONS, AND ACCESSIBLE ONLINE MATERIALS, OUR PATIENT PROGRAMS PROMOTE SELF-ADVOCACY, INFORMED DECISION-MAKING, AND ONGOING COMMUNITY CONNECTION.
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Todd HammerTODD HAMMER
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 3
-
R Bennett MuskinR BENNETT MUSKIN
SECRETARY
- Total calculated
- $0
- Hours/week
- 3
-
Alice BastALICE BAST
EXECUTIVE DIRECTOR
- Total calculated
- $350,333
- From this org
- $344,615
- From related orgs
- $0
- Other
- $5,718
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $284,615
- Bonus
- $60,000
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $5,718
- Filer's total
- $350,333
-
Lawrence P Flynn CPALAWRENCE P FLYNN CPA
TREASURER
- Total calculated
- $0
- Hours/week
- 4
-
Alan M Ehrlich MDALAN M EHRLICH MD
CHAIR
- Total calculated
- $0
- Hours/week
- 4
-
Lisa R AgdernLISA R AGDERN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 4
-
James AndrewsJAMES ANDREWS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Zack BogerZACK BOGER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 3
-
C Kane BrenanC KANE BRENAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Arturo Chacon CruzARTURO CHACON CRUZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Valerie CohnVALERIE COHN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Sharon GaffneySHARON GAFFNEY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Carole Haas GravagnoCAROLE HAAS GRAVAGNO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Doug JacobsteinDOUG JACOBSTEIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jaime LipsonJAIME LIPSON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Alison Reemer SolomonALISON REEMER SOLOMON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Brittany BakerBRITTANY BAKER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jennifer BrownsteinJENNIFER BROWNSTEIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Barb Weir PowersBARB WEIR POWERS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Sarena SniderSARENA SNIDER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jennifer Platzkere Snyder EsqJENNIFER PLATZKERE SNYDER ESQ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Mary Kate CarofanoMARY KATE CAROFANO
CHIEF OPERATING OFFICER
- Total calculated
- $225,000
- From this org
- $225,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $225,000
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $225,000
-
Angela CristANGELA CRIST
DIRECTOR OF COMMUNICATIONS
- Total calculated
- $109,004
- From this org
- $109,004
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
George GorgeGEORGE GORGE
SENIOR DIRECTOR OF FINANCE
- Total calculated
- $102,342
- From this org
- $102,342
- From related orgs
- $0
- Other
- $0
- Hours/week
- 35
-
Debra SilbergDEBRA SILBERG
CHIEF SCIENTIFIC OFFICER
- Total calculated
- $130,343
- From this org
- $130,343
- From related orgs
- $0
- Other
- $0
- Hours/week
- 20
-
Mary TackettMARY TACKETT
SENIOR DIRECTOR OF PHILANTHROPY
- Total calculated
- $103,262
- From this org
- $103,262
- From related orgs
- $0
- Other
- $0
- Hours/week
- 32
-
Eric WhiteERIC WHITE
DIRECTOR OF BUSINESS DEVELOPMENT
- Total calculated
- $105,692
- From this org
- $105,692
- From related orgs
- $0
- Other
- $0
- Hours/week
- 30
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$70,000
RESEARCH
Fundraising and gaming
From Schedule G of this return, as filed.
- Had an agreement with a professional fundraiser (line 2a)
- Not answered
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 GALA | Event 2 5K STEP BEYOND | Other events 2 events | Total |
|---|---|---|---|---|
| Gross receipts (line 1) | $431,799 | $149,304 | $25,920 | $607,023 |
| Less contributions (line 2) | — | — | — | — |
| Gross income (line 3) | $431,799 | $149,304 | $25,920 | $607,023 |
| Cash prizes (line 4) | — | — | — | — |
| Noncash prizes (line 5) | — | — | — | — |
| Rent and facility costs (line 6) | — | — | — | — |
| Food and beverages (line 7) | — | — | — | — |
| Entertainment (line 8) | — | — | — | — |
| Other direct expenses (line 9) | $39,283 | $24,766 | $1,133 | $65,182 |
- Direct expenses (line 10)
- $65,182
- Net income (line 11)
- $541,841
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $0
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| UNITED KINGDOM | $67,047 | CHECK | $0 | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 1
- Other grantees (Part II line 3)
- —
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 11 September 2026
- IRS schema version
- 2024v5.5
- Source object
- 202622579349300877
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.